BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 6142433)

  • 21. [Use of a prolonged-action beta-blocker (nadolol) in the therapy of stable angina. Ergometric study].
    Galati A; Coletta C; Carunchio A; Bordi L; Salustri A; Tornese C; Cigna G
    Minerva Cardioangiol; 1985 Dec; 33(12):845-50. PubMed ID: 2869449
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of tolamolol versus propranolol on systolic time intervals in angina.
    Aronow WS; Vawter M; Spivack N; Warren M; Laverty W
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1069-76. PubMed ID: 4154826
    [No Abstract]   [Full Text] [Related]  

  • 23. [Evaluation, by the bicycle ergometry test ECG, of the efficacy of a single dosage of nadolol, in patients with stable angina pectoris].
    Capuano V; De Vita S; Riccio MD; De Martino M; Mondillo G
    Minerva Cardioangiol; 1985 Nov; 33(11):739-44. PubMed ID: 2868431
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effectiveness and limitations of adrenergic beta receptor blocking in the treatment of the stenocardia syndrome and of some disorders of cardiac rhythm: clinical trial with INPEA (N-isopropyl-p-mitrophenylethanolamine)].
    Piva M; Ongari R; Dotti F
    Clin Ter; 1968 Oct; 47(1):53-84. PubMed ID: 4393774
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on a new beta-receptor blocking drug, tobanum--1-(2,5-dichlorophenoxy)-3-tertiary-butylamino-2-propanol HCl: its use in cardiovascular hyperkinetic syndrome, hypertension, and angina pectoris, and its effect on respiration.
    Szám I; Büky P; Gulyás A; Sinkovics M
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):128-33. PubMed ID: 6121761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacologic properties and therapeutic use of beta adrenergic receptor blocking drugs].
    Shanks RG
    Medicina (B Aires); 1979; 39 Suppl 1():87-99. PubMed ID: 45034
    [No Abstract]   [Full Text] [Related]  

  • 27. [Penbutolol--a sinistrorotatory adrenergic beta-receptor blocking agent. Ergometer investigations in patients with angina pectoris].
    Prahl P; Prahl M
    Ugeskr Laeger; 1973 May; 135(20):965-8. PubMed ID: 4148295
    [No Abstract]   [Full Text] [Related]  

  • 28. [Beta blocker therapy. New aspects--outdated opinions. Interview by G. Riecker].
    Werdan K
    Internist (Berl); 1992 Sep; 33(9):618-21. PubMed ID: 1356943
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy and safety of nadolol in angina pectoris.
    Cruz J; Conceicao JM; Coelho EM
    Practitioner; 1982 Aug; 226(1370):1452-3. PubMed ID: 6127670
    [No Abstract]   [Full Text] [Related]  

  • 30. [Seloken (Metoprolol, Hässle)].
    Hjemdahl P
    Lakartidningen; 1976 Mar; 73(12):1092. PubMed ID: 3701
    [No Abstract]   [Full Text] [Related]  

  • 31. [Metoprolol, a new cardioselective beta blocking agent in the treatment of arterial hypertension].
    Pedersen OL
    Ugeskr Laeger; 1975 Sep; 137(39):2274-6. PubMed ID: 241148
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of the adrenergic selective beta 1-blocker cordanum in the treatment of patients with angina pectoris complicating pulmonary pathology].
    Shastin NN; Zhuk AE; Zhivotov KA
    Sov Med; 1982; (10):11-6. PubMed ID: 6129708
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evaluation of beta-blocking treatments efficiency in angina pectoris and cardiac arrythmia (author's transl)].
    Coumel P; Witchitz S
    Therapie; 1980; 35(2):137-46. PubMed ID: 6106304
    [No Abstract]   [Full Text] [Related]  

  • 34. The use of beta-adrenergic blockers in the treatment of angina and hypertension. A clinical symposium. 31st annual meeting, American College of Angiology and 21st annual meeting, International College of Angiology. San Antonio, Texas, November 6, 1984.
    Angiology; 1986 Mar; 37(3 Pt 2):215-62. PubMed ID: 2871778
    [No Abstract]   [Full Text] [Related]  

  • 35. [Beta-adrenergic receptor blocking agents].
    Hayase S; Ito H
    Nihon Rinsho; 1970 Mar; 28 Suppl():680-3. PubMed ID: 4393440
    [No Abstract]   [Full Text] [Related]  

  • 36. [Long-term studies on the beta blocker talinolol (cordanum) with special reference to side effects].
    Mann D; Boguschewski KD; Brämer U; Dobritz H; Hitzeroth T
    Z Gesamte Inn Med; 1979 Apr; 34(7):192-5. PubMed ID: 39387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical study of a new beta-blocking agent: LB 46].
    Warembourg H; Ducloux G
    Lille Med; 1971 Oct; 16():Suppl 4:1203-8. PubMed ID: 4399711
    [No Abstract]   [Full Text] [Related]  

  • 38. [Beta blockaders in the treatment of cardio- and circulatory disorders].
    Cottier P; Seiler A
    Wien Med Wochenschr; 1976 Oct; 126(42-44):601-8. PubMed ID: 11612
    [No Abstract]   [Full Text] [Related]  

  • 39. [A cardio-selective beta blockader: practolol].
    Biron P
    Union Med Can; 1971 May; 100(5):973-4. PubMed ID: 4147302
    [No Abstract]   [Full Text] [Related]  

  • 40. [New specialty drugs registered in Austria. Concor].
    Graffius D
    Wien Klin Wochenschr; 1990 Mar; 102(6):180-4. PubMed ID: 1970446
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.